Sign inJoin waitlistJoin the waitlist

YZ

Youli Zu

Medical Director, Hematopathology Section · Houston Methodist Hospital

Credentials: · · · · ·

History

Hematopathology Section · Houston Methodist Hospital
Present

National Cancer Institute
2001–2002
New York University
1998–2002
Internal Medicine
1982–1985
Jilin Medical College Hospital | 1982
1981–1982
Jilin Medical University
1978–1982

Research

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression…
Blood · 2013 · 576 citations
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins
Journal of Clinical Oncology · 2014 · 427 citations
Oligonucleotide aptamers: new tools for targeted cancer therapy
Molecular Therapy — Nucleic Acids · 2014 · Last of 6 authors · Corresponding · 381 citations

Govind Bhagat
37 papers
Ken Young
37 papers
Eric Hsi
36 papers
April Chiu
34 papers
Jane Winter
31 papers
Jeffrey Medeiros
25 papers
BP
Benjamin Parsons
24 papers
Attilio Orazi
23 papers
CC
Chung-Che Chang
22 papers
KR
Kristy Richards
22 papers
WT
Wayne Tam
13 papers
RM
Roberto Miranda
12 papers

Grants

Self-Assembled Multifunctional Aptamer-Complex Biomaterial for Precision Medicine
National Cancer Institute · R01
Contact PI · $1.8M · Methodist Hospital Research Institute
2018–2024
Integrative Analysis of Cancer Single-Cell Transcriptomic and Functional Proteomic Data (2 of 2)
National Cancer Institute · R21
PI · $774.2K · Methodist Hospital Research Institute
2015–2018
A Simple Assay System for Rapid Detection of Circulating Tumor Cells
National Cancer Institute · R41
PI · $330.7K · Telovision, Llc
2014–2017
RFA-CA -12-003 - Activatable One-Drop and One-Step Assay for Circulating Tumor Ce
National Cancer Institute · R33
Contact PI · $1.1M · Methodist Hospital Research Institute
2012–2016